Clinical Trial

Maintenance Venetoclax in AML Fit Patients

Name: Maintenance Venetoclax in AML Fit Patients — clinical trial record (NCT07244367)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

this study will explore the efficacy of maintenance SC cytarabine + venetoclax therapy as regard disease free survival (DFS) in AML fit patients who achieved CR after highly aggressive chemotherapy as bridge for BMT or if BMT will be delayed or canceled due to any other reason.

Trial Details

NCT Number	NCT07244367
Lead Sponsor	Sohag University
Conditions	Acute Myeloid Leukaemia (AML)
Enrollment	80 participants
Start Date	2025-09-01
Primary Completion	2026-09-01 (estimated)
Study Completion	2027-09-01 (estimated)
Updated on ClinicalTrials.gov	2025-11-24